Oxygenta Pharmaceutical Intrinsic Value
OXYGENTAPH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹61.08 | ₹54.97 - ₹67.19 | +9.7% | Revenue/Share: ₹30.54, P/S: 2.0x |
Want to compare with current market value? Check OXYGENTAPH share price latest .
Valuation Comparison Chart
OXYGENTAPH Intrinsic Value Analysis
What is the intrinsic value of OXYGENTAPH?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Oxygenta Pharmaceutical (OXYGENTAPH) is ₹61.08 (median value). With the current market price of ₹55.70, this represents a +9.7% variance from our estimated fair value.
The valuation range spans from ₹61.08 to ₹61.08, indicating ₹61.08 - ₹61.08.
Is OXYGENTAPH undervalued or overvalued?
Based on our multi-method analysis, Oxygenta Pharmaceutical (OXYGENTAPH) appears to be trading near calculated value by approximately 9.7%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.35 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | -3.32 | Industry Standard: <0.5 | Below 0.5 | Indicates financial leverage level |
| Return on Equity | 68.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -24.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.36x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Oxygenta Pharmaceutical
Additional stock information and data for OXYGENTAPH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹3 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-13 Cr | ₹-15 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-2 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-2 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |